AIM ImmunoTech advances Ampligen for avian influenza vaccine
Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...
Aim is 30 — expect muted celebrations, but all is not lost
A sub-market of the London Stock Exchange, Aim — formerly the Alternative Investment Market — will turn 30 this year. But any celebrations are likely to be muted.
ARLnow.com2d
AIM renews calls for county help as ‘hard deadline’ to reboot WERA 96.7 approaches
An impending deadline for Arlington Independent Media's broadcasting license is reinvigorating the nonprofit's requests for ...
Tariff threats take aim at fentanyl trafficking. Here’s how the drug reaches the US
President Donald Trump's threat of tariffs on goods from Mexico, Canada and China is aimed at stopping the flow of fentanyl ...
Marseille aim to develop amputee football with new team
Olympique de Marseille are no strangers to being trailblazers in French football and they have set yet another benchmark by ...